Connor, Clark & Lunn Investment Management (CC&L)’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21,219
Closed -$9.49M 1650
2025
Q3
$9.49M Buy
21,219
+20,505
+2,872% +$9.84M 0.03% 425
2025
Q2
$388K Sell
714
-52,789
-99% -$27.6M ﹤0.01% 1310
2025
Q1
$26.5M Buy
53,503
+46,228
+635% +$25.6M 0.12% 148
2024
Q4
$3.8M Sell
7,275
-15,841
-69% -$8.25M 0.02% 558
2024
Q3
$11.4M Buy
+23,116
New +$10.8M 0.06% 248
2024
Q2
Sell
-4,165
Closed -$1.66M 1524
2024
Q1
$1.66M Buy
+4,165
New +$1.57M 0.01% 726
2023
Q3
Sell
-3,719
Closed -$1.27M 1445
2023
Q2
$1.27M Buy
+3,719
New +$1.13M 0.01% 724
2022
Q4
Sell
-45,008
Closed -$8.44M 1323
2022
Q3
$8.44M Buy
45,008
+6,951
+18% +$1.49M 0.06% 230
2022
Q2
$7.64M Sell
38,057
-1,150
-3% -$270K 0.05% 238
2022
Q1
$11.8M Buy
39,207
+28,652
+271% +$8.37M 0.06% 205
2021
Q4
$3.79M Sell
10,555
-36,767
-78% -$12.6M 0.02% 390
2021
Q3
$15.7M Sell
47,322
-72,378
-60% -$24.3M 0.08% 174
2021
Q2
$36.7M Sell
119,700
-8,583
-7% -$2.41M 0.19% 104
2021
Q1
$31.6M Buy
128,283
+65,175
+103% +$16.4M 0.18% 114
2020
Q4
$17.2M Buy
63,108
+30,531
+94% +$7.58M 0.1% 153
2020
Q3
$7.71M Buy
32,577
+17,055
+110% +$3.83M 0.05% 240
2020
Q2
$2.95M Sell
15,522
-93,798
-86% -$16.8M 0.02% 388
2020
Q1
$18M Sell
109,320
-13,200
-11% -$2.42M 0.16% 109
2019
Q4
$24.1M Sell
122,520
-27,075
-18% -$5.07M 0.17% 107
2019
Q3
$26.9M Buy
149,595
+37,200
+33% +$6.43M 0.18% 105
2019
Q2
$19.7M Buy
112,395
+98,175
+690% +$16.8M 0.13% 123
2019
Q1
$2.71M Buy
14,220
+3,000
+27% +$533K 0.02% 368
2018
Q4
$1.79M Buy
11,220
+495
+5% +$83.9K 0.01% 436
2018
Q3
$2.05M Sell
10,725
-48,675
-82% -$8.64M 0.01% 429
2018
Q2
$9.47M Buy
59,400
+42,075
+243% +$6.42M 0.05% 221
2018
Q1
$2.38M Buy
17,325
+375
+2% +$52.3K 0.01% 367
2017
Q4
$2.06M Buy
16,950
+1,425
+9% +$178K 0.01% 416
2017
Q3
$1.8M Buy
15,525
+3,825
+33% +$417K 0.01% 440
2017
Q2
$1.22M Sell
11,700
-102,825
-90% -$9.88M 0.01% 466
2017
Q1
$9.75M Buy
114,525
+36,000
+46% +$2.84M 0.06% 181
2016
Q4
$5.53M Buy
78,525
+61,425
+359% +$4.52M 0.04% 235
2016
Q3
$1.38M Buy
17,100
+9,900
+138% +$758K 0.01% 421
2016
Q2
$529K Buy
7,200
+3,600
+100% +$253K ﹤0.01% 573
2016
Q1
$240K Buy
+3,600
New +$223K ﹤0.01% 689
2015
Q4
Sell
-9,900
Closed -$506K 838
2015
Q3
$506K Buy
+9,900
New +$561K ﹤0.01% 521
2015
Q1
Sell
-5,400
Closed -$317K 592
2014
Q4
$317K Sell
5,400
-5,400
-50% -$301K ﹤0.01% 454
2014
Q3
$554K Buy
+10,800
New +$536K ﹤0.01% 375
2014
Q1
Sell
-8,865
Closed -$402K 724
2013
Q4
$402K Buy
+8,865
New +$373K ﹤0.01% 538

Other funds holding ISRG

Connor, Clark & Lunn Investment Management (CC&L)'s ISRG Position: Q4 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Intuitive Surgical (ISRG) in Q4 2025, closing a stake of 21,219 shares — an estimated $9.49M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ISRG in Q4 2013 and held it in 38 quarters. The position peaked at $36.7M in Q2 2021. 2,415 funds tracked by Wall St. Rank hold ISRG as of Q4 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Intuitive Surgical position as of Q4 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 21,219 Intuitive Surgical shares in Q4 2025, an estimated $9.49M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Intuitive Surgical in Q4 2013 and held it in 38 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Intuitive Surgical position peaked at $36.7M in Q2 2021.
  • 2,415 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2025, filed 10 Feb 2026.